In the absence of FDA-approved long COVID treatments, desperate patients look to alternative medicine. Here’s a look at what ...

Kestra Medical Technologies today announced primary results from a post-approval study of its wearable cardioverter ...

Kestra Medical Technologies Ltd. ( ($KMTS) ) just unveiled an announcement. On November 10, 2025, Kestra Medical Technologies announced the ...

Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced ...

A study was conducted to compare cardiovascular and mortality outcomes following COVID-19 vs influenza infection using real-world data.

A simple imaging exam capable of assessing myocardial deformation during contraction has emerged as a promising tool for ...

In this video, Medora Rodrigues, MD, a hospitalist at The Ohio State University Wexner Medical Center, discusses a case of histoplasmosis-associated necrotizing granulomatous hepatitis linked to ...

According to Precedence Research, the global wearable cardiac devices market size will grow from USD 4.68 billion in 2025 to ...

Even though the emergency room doctors were eventually able to refer her to an internal medicine specialist, which in turn ...

Penumbra (NYSE:PEN) announced additional results from its STORM-PE trial of computer-assisted vacuum thrombectomy (CAVT).

Kestra Medical (KMTS) announced primary results from the ASSURE WCD Clinical Evaluation Post-Approval Study, presented as a late-breaking science ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biotechnology company, today announced that Seth Lederman, M.D., Tonix’s Chief Executive ...